Expression of anti and pro‐inflammatory genes in human endothelial cells activated by 25‐hydroxycholesterol: A comparison of rivaroxaban and dabigatran
P Gorzelak‐Pabiś, A Pawlos, M Broncel… - Clinical and …, 2022 - Wiley Online Library
Atherosclerosis is associated with a haemostatic imbalance characterized by excessive
activation of pro‐inflammatory and pro‐coagulant pathways. Non‐vitamin K antagonists oral …
activation of pro‐inflammatory and pro‐coagulant pathways. Non‐vitamin K antagonists oral …
Intraocular Bleeding in Patients With Atrial Fibrillation Treated With NOACs VS. Warfarin: A Systematic Review and Meta-Analysis
F Liu, Y Zhang, J Luo, Y Zhou - Frontiers in Cardiovascular Medicine, 2022 - frontiersin.org
Background Intraocular bleeding is a devastating adverse event for patients with atrial
fibrillation (AF) receiving anticoagulant therapy. It is unknown whether non-vitamin K oral …
fibrillation (AF) receiving anticoagulant therapy. It is unknown whether non-vitamin K oral …
Effect of direct oral anticoagulants in patients with atrial fibrillation with mitral or aortic stenosis: A review
G Guo, S Liang, Z Guan, K Zhu - Frontiers in Cardiovascular Medicine, 2022 - frontiersin.org
Background Several studies have summarized the clinical performance of direct oral
anticoagulants (DOACs) in atrial fibrillation (AF) patients with mitral stenosis or aortic …
anticoagulants (DOACs) in atrial fibrillation (AF) patients with mitral stenosis or aortic …
[PDF][PDF] Arzneimittelreport 2022
D Grandt, V Lappe, I Schubert - barmer.de
Klar ist, die Ärztinnen und Ärzte müssen für arzneitherapeutische Entscheidungen alle
Diagnosen und die Medikation ihrer Patienten kennen. Die elektronische Patientenakte …
Diagnosen und die Medikation ihrer Patienten kennen. Die elektronische Patientenakte …
Efficacy and safety evaluation of rivaroxaban vs. warfarin among non-valvular atrial fibrillation patients undergoing lower extremity revascularization
Q Yu, C Chen, J Xu, Y Xiao, J Bao… - Frontiers in Cardiovascular …, 2022 - frontiersin.org
Introduction The efficacy and safety of antithrombotic strategies remain uncertain in patients
with atrial fibrillation undergoing lower-extremity revascularisation. Materials and methods …
with atrial fibrillation undergoing lower-extremity revascularisation. Materials and methods …